Cattlyst 50g is a drug owned by PHIBRO ANIMAL HEALTH CORP. It is protected by 1 US drug patent filed in 2029. All patents are active. Details of Cattlyst 50g’s patents and their expiration are given below.
| Drug Patent Number | Drug Patent Expiry | Status |
|---|---|---|
 | ||
| US9149456 | Active | |
About Cattlyst 50g
Cattlyst 50g is a drug
owned by PHIBRO ANIMAL HEALTH CORP.
Cattlyst 50g uses
Laidlomycin Propionate Potassium as the active
ingredient.
Active Ingredient:
Cattlyst 50g uses
Laidlomycin Propionate Potassium as the active ingredient.
Check out other Drugs and Companies using
Laidlomycin Propionate Potassium ingredient.